SUMMARY
Upon infection, CD8+ T cells undergo a stepwise process of early activation, expansion and differentiation into effector cells. How these phases are transcriptionally regulated is incompletely defined. Here, we report that interferon regulatory factor 4 (IRF4), dispensable for early CD8+ T cell activation, was vital for sustaining the expansion and effector differentiation of CD8+ T cells. Mechanistically, IRF4 promoted the expression and function of Blimp1 and T-bet, two transcription factors required for CD8+ T cell effector differentiation, while repressed genes that mediate cell cycle arrest and apoptosis. Selective ablation of Irf4 in peripheral CD8+ T cells impaired anti-viral CD8+ T cell responses, viral clearance and CD8+ T cell-mediated host recovery from influenza infection. IRF4 expression was regulated by T cell receptor (TCR) signaling strength via mammalian target of rapamycin (mTOR). Our data reveal that IRF4 translates differential strength of TCR-signaling into different quantitative and qualitative CD8+ T cell responses.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.